Treating Muscular Dystrophy with CRISPR Gene Editing
Type
Blog Post
Published
Jan. 26, 2016, 3:30 p.m.
... important proof of concept for future preclinical and clinical work.
Find Plasmids for Disease Research...research, researchers are eager to apply it in a clinical setting. CRISPR is often used for animal germline...exon skipping is a good option for DMD treatment. Clinical trials have used oligonucleotide exon skipping...rate of exon 51, which resulted in appropriately localized dystrophin. In a subsequent study, they used CRISPR...six months.
Future directions and obstacles to clinical CRISPR editing
Given the success of the CRISPR-mediated...be evaluated separately, increasing the time to clinical approval.
Even with the challenges precision editing...become one of the first diseases to be treated clinically with CRISPR. Many obstacles remain for CRISPR...